Alan Garber discusses tiered co-payment findings in Wall Street Journal article

To control rising health-care costs, employers are increasingly requiring employees to pay higher co-payments for expensive brand-name medications. But a recent Harvard study found that when confronted with higher co-payments, many people stop taking their medications entirely, which could jeopardize their health. CHP/PCOR director Alan M. Garber comments on the findings in a Dec. 4 Wall Street Journal article.